Page last updated: 2024-08-23

diltiazem and Hyperlipidemias

diltiazem has been researched along with Hyperlipidemias in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (42.86)	18.7374
1990's	2 (28.57)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (28.57)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Palmer, OM; Rhoads, DD; Sivak, RA	1
Corr, C; De Lepeleire, I; Garg, A; Handa, N; Jin, B; Krishna, R; Maes, A; Shah, J; Van Dyck, K; Wadhwa, T; Wagner, JA	1
Carré, A; Joire, JE; Lequeuche, B; Mounier-Vehier, C	1
Masaki, K; Nakayama, M; Wada, S	1
Dolphin, PJ; Graham, SE; Russell, JC; Stewart, B	1
Birou, S	1
Birou, S; Fukunaga, H; Kakei, M; Kashima, T; Saito, K; Tanaka, H	1

Trials

1 trial(s) available for diltiazem and Hyperlipidemias

Article	Year
Effect of diltiazem, a moderate CYP3A inhibitor, on the pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein inhibitor, in healthy subjects. Journal of clinical pharmacology, 2011, Volume: 51, Issue:3 Topics: Adolescent; Adult; Cholesterol Ester Transfer Proteins; Cytochrome P-450 CYP3A Inhibitors; Delayed-Action Preparations; Diltiazem; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Hyperlipidemias; Linear Models; Male; Middle Aged; Oxazolidinones; Young Adult	2011

Article

Year

Effect of diltiazem, a moderate CYP3A inhibitor, on the pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein inhibitor, in healthy subjects.

Journal of clinical pharmacology, 2011, Volume: 51, Issue:3

Topics: Adolescent; Adult; Cholesterol Ester Transfer Proteins; Cytochrome P-450 CYP3A Inhibitors; Delayed-Action Preparations; Diltiazem; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Hyperlipidemias; Linear Models; Male; Middle Aged; Oxazolidinones; Young Adult

2011

Other Studies

6 other study(ies) available for diltiazem and Hyperlipidemias

Article	Year
Plasma abnormalities following overdose. Clinical chemistry, 2014, Volume: 60, Issue:7 Topics: Color; Diltiazem; Drug Overdose; Fat Emulsions, Intravenous; Female; Food-Drug Interactions; Hemolysis; Humans; Hyperlipidemias; Middle Aged; Off-Label Use; Plasma; Poisoning; Tetrazoles; Valine; Valsartan	2014
[Effect of diltiazem on lipid profiles and heart rate in hypertensive patients]. Annales de cardiologie et d'angeiologie, 1999, Volume: 48, Issue:3 Topics: Aged; Antihypertensive Agents; Apolipoprotein A-I; Blood Pressure; Calcium Channel Blockers; Cholesterol; Cholesterol, LDL; Diltiazem; Edema; Electrocardiography; Female; Flushing; Headache; Heart Rate; Humans; Hyperlipidemias; Hypertension; Leg; Male; Middle Aged; Treatment Outcome	1999
Effects of diltiazem hydrochloride on serum lipids: comparison with beta-blockers. Clinical therapeutics, 1982, Volume: 5, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Benzazepines; Blood Glucose; Carbohydrate Metabolism; Diabetes Mellitus; Diltiazem; Female; Humans; Hyperlipidemias; Lipid Metabolism; Lipids; Male; Middle Aged; Sex Factors; Triglycerides	1982
Sexual dimorphism in the metabolic response to the calcium channel antagonists, diltiazem and clentiazem, by hyperlipidemic JCR:LA-cp rats. Biochimica et biophysica acta, 1995, Sep-14, Volume: 1258, Issue:2 Topics: Animals; Body Weight; Calcium Channel Blockers; Diltiazem; Female; Glucose; Hyperlipidemias; Insulin; Lipids; Lipoproteins; Male; Rats; Rats, Mutant Strains; Sex Factors	1995
[Studies on the mechanisms of the antiatherogenic effect of Ca-antagonists]. Igaku kenkyu. Acta medica, 1988, Volume: 58, Issue:2 Topics: Animals; Arteriosclerosis; Calcium Channel Blockers; Cells, Cultured; Diltiazem; Endothelium, Vascular; Humans; Hyperlipidemias; Muscle, Smooth, Vascular; Rabbits	1988
Diltiazem prevents the damage to cultured aortic smooth muscle cells induced by hyperlipidemic serum. Experientia, 1986, Apr-15, Volume: 42, Issue:4 Topics: Animals; Aorta; Benzazepines; Cell Survival; Cells, Cultured; Culture Media; Diltiazem; Hyperlipidemias; Kinetics; Muscle, Smooth, Vascular; Rabbits	1986